Biotechnology

Filter

Current filters:

None

Popular Filters

2126 to 2150 of 2409 results

Sandoz to emphasize need for consistent regulatory standards across all biologics at FDA hearings

10-05-2012

Germany-based Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX) announced that Mark McCamish,…

BiotechnologyGeneralNorth AmericaNovartisRegulationResearchSandoz

GlaxoSmithKline goes on attack over Human Genome bid

09-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) went into attack mode this morning, taking its unsolicited…

BiotechnologyGlaxoSmithKlineHuman Genome SciencesMarkets & MarketingPharmaceutical

Intellect Neurosciences adds to its Alzheimer's development pipeline

08-05-2012

US biopharma firm Intellect Neurosciences (OTCBB: ILNS) has announced two new programs in its Alzheimer's…

BiotechnologyIntellect NeuroscienceLicensingNeurological

Therapeutic monoclonal antibodies market - Is Biologics the answer to rising disease incidence?

08-05-2012

Existing adoption rates and commercial success of launched monoclonal antibodies (MAbs) for therapeutics…

BiotechnologyEuropeMarkets & Marketing

Sunshine Act data collection delayed to January 2013, says USA's CMS

08-05-2012

In a web site posting last week, The US Center for Medicare and Medicaid Services (CSM) announced that…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Life sciences M&A activity heats Up in April, says Burrill & Co

07-05-2012

April proved to be a big month for M&A activity in the life sciences as companies announced more than…

BiotechnologyFinancialMergers & AcquisitionsPharmaceutical

US NIH debuts collaborative program with Pharma to spur therapeutic development

07-05-2012

The US National Institutes of Health last week unveiled a collaborative program that will match researchers…

AstraZenecaBiotechnologyEli LillyNorth AmericaPfizerPharmaceuticalResearch

GAO report finds that USA's FDA has met most PDUFA performance goals

04-05-2012

A report dated March 30 but only released earlier this week by the US Government Accountability Office…

BiotechnologyNorth AmericaPharmaceuticalRegulation

New biologics and biosimilars approval guidelines in Mexico

04-05-2012

In Mexico, new guidelines are now in effect for the market authorization of biologics and biosimilars,…

BiotechnologyGenericsRegulationSouth America

Genzyme gains FDA and EMA approval for Irish production plant

03-05-2012

US biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) said yesterday that…

BiotechnologyEuropeGenzymeLumizymeMyozymeRegulationSanofi

Unmet needs in orphan diseases therapy offer opportunity for Big Pharma; report

03-05-2012

Patients suffering from orphan diseases can look forward to a wider range of drug options in the future,…

BiotechnologyMarkets & MarketingPharmaceuticalRare diseasesResearch

Patient perspectives influencing drug development

02-05-2012

Support is growing for increased collaboration between pharmaceutical companies and patients in research…

BiotechnologyPharmaceuticalRegulationResearch

Biogen Idec 1st-qtr sales up 7% but fail to match expectations

02-05-2012

US biotech company Biogen Idec (Nasdaq: BIIB) post first-quarter 2012 sales of $1.29 billion, a rise…

Biogen IdecBiotechnologyFinancial

New business model to relaunch the BioPharma industry, from ADL

01-05-2012

Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

Actelion's macitentan meets primary endpoint in pivotal Phase III PAH study

01-05-2012

Europe's largest biotech company, Actelion (SIX: ATLN), says that initial analysis indicates that the…

ActelionBiotechnologymacitentanResearchRespiratory and Pulmonary

Biopharmaceuticals "no longer a growth market" in Germany

30-04-2012

After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPoliticsPricingRegulation

FDA stalls Amgen's Xgeva sBLA for prevention of bone metastases

30-04-2012

USA-based Amgen (Nasdaq: AMGN) revealed on Friday that the US Food and Drug Administration has issued…

AmgenBiotechnologyNorth AmericaOncologyRegulationXgeva

BIO asks US House Committee on Ways and Means to extend critical tax provisions; backs Obama Bioeconomy Blueprint

29-04-2012

US trade group the Biotechnology Industry Organization (BIO) has submitted a statement for the record…

BiotechnologyFinancialNorth AmericaPolitics

2126 to 2150 of 2409 results

Parexel

Parexel

Back to top